Literature DB >> 31811585

Movement Disorder in Copper Toxicity Rat Model: Role of Inflammation and Apoptosis in the Corpus Striatum.

Jayantee Kalita1, Vijay Kumar2, Usha K Misra3, Himangsu K Bora4.   

Abstract

The pattern of copper (Cu) toxicity in humans is similar to Wilson disease, and they have movement disorders and frequent involvement of corpus striatum. The extent of cell deaths in corpus striatum may be the basis of movement disorder and may be confirmed in the experimental study. To evaluate the extent of apoptosis and glial activation in corpus striatum following Cu toxicity in a rat model, and correlate these with spontaneous locomotor activity (SLA), six male Wistar rats were fed normal saline (group I) and another six were fed copper sulfate 100 mg/kgBWt/daily orally (group II). At 1 month, neurobehavioral studies including SLA, rotarod, and grip strength were done. Corpus striatum was removed and was subjected to glial fibrillary acidic protein (GFAP) and caspase-3 immunohistochemistry. The concentration of tissue Cu, total antioxidant capacity (TAC), glutathione (GSH), malondialdehyde (MDA), and glutamate were measured. Group II rats had higher expression of caspase-3 (Mean ± SEM 32.67 ± 1.46 vs 4.47 ± 1.08; p < 0.01) and GFAP (41.81 ± 1.68 vs 31.82 ± 1.27; p < 0.01) compared with group I. Neurobehavioral studies revealed reduced total distance traveled, time moving, the number of rearing, latency to fall on the rotarod, grip strength, and increased resting time compared with group I. The expression of GFAP and caspase-3 correlated with SLA parameters, tissue Cu, GSH, MDA, TAC, and glutamate levels. The impaired locomotor activity in Cu toxicity rats is due to apoptotic and inflammatory-mediated cell death in the corpus striatum because of Cu-mediated oxidative stress and excitotoxicity.

Entities:  

Keywords:  Copper toxicity; Corpus striatum; Movement disorder; Oxidative stress; Spontaneous locomotor activity; Wilson disease

Mesh:

Substances:

Year:  2019        PMID: 31811585     DOI: 10.1007/s12640-019-00140-9

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  57 in total

1.  Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid.

Authors:  Dorothea Strozyk; Lenore J Launer; Paul A Adlard; Robert A Cherny; Andrew Tsatsanis; Irene Volitakis; Kaj Blennow; Helen Petrovitch; Lon R White; Ashley I Bush
Journal:  Neurobiol Aging       Date:  2007-12-18       Impact factor: 4.673

Review 2.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

Review 3.  Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases.

Authors:  Wei Zheng; Andrew D Monnot
Journal:  Pharmacol Ther       Date:  2011-11-13       Impact factor: 12.310

4.  Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects.

Authors:  L De Riccardis; A Buccolieri; M Muci; E Pitotti; F De Robertis; G Trianni; D Manno; M Maffia
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-03-08       Impact factor: 5.187

5.  Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms.

Authors:  Radan Bruha; Libor Vitek; Zdenek Marecek; Lenka Pospisilova; Sona Nevsimalova; Pavel Martasek; Jaromir Petrtyl; Petr Urbanek; Alena Jiraskova; Ivana Malikova; Martin Haluzik; Peter Ferenci
Journal:  J Inherit Metab Dis       Date:  2011-12-03       Impact factor: 4.982

6.  Oxidative damage to rat brain in iron and copper overloads.

Authors:  Rosario Musacco-Sebio; Nidia Ferrarotti; Christian Saporito-Magriñá; Jimena Semprine; Julián Fuda; Horacio Torti; Alberto Boveris; Marisa G Repetto
Journal:  Metallomics       Date:  2014-08       Impact factor: 4.526

7.  Patterns of levels of biological metals in CSF differ among neurodegenerative diseases.

Authors:  Isao Hozumi; Tatsuya Hasegawa; Akiko Honda; Kazuhiro Ozawa; Yuichi Hayashi; Kazunori Hashimoto; Megumi Yamada; Akihiro Koumura; Takeo Sakurai; Akio Kimura; Yuji Tanaka; Masahiko Satoh; Takashi Inuzuka
Journal:  J Neurol Sci       Date:  2011-02-02       Impact factor: 3.181

8.  Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy.

Authors:  Jayantee Kalita; Vijay Kumar; Abhay Ranjan; Usha K Misra
Journal:  Neuromolecular Med       Date:  2015-07-30       Impact factor: 3.843

Review 9.  Neurotoxicity of Copper.

Authors:  Felix Bulcke; Ralf Dringen; Ivo Florin Scheiber
Journal:  Adv Neurobiol       Date:  2017

10.  Third BIR domain of XIAP binds to both Cu(II) and Cu(I) in multiple sites and with diverse affinities characterized at atomic resolution.

Authors:  Shen-Na Chen; Tian Fang; Jing-Yang Kong; Bin-Bin Pan; Xun-Cheng Su
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

View more
  4 in total

1.  Movement Disorder in Wilson Disease: Correlation with MRI and Biomarkers of Cell Injury.

Authors:  Jayantee Kalita; Vijay Kumar; Usha K Misra; Sunil Kumar
Journal:  J Mol Neurosci       Date:  2020-07-13       Impact factor: 3.444

2.  Neuropsychiatric Manifestations of Wilson Disease: Correlation with MRI and Glutamate Excitotoxicity.

Authors:  Jayantee Kalita; Vijay Kumar; Vasudev Parashar; Usha K Misra
Journal:  Mol Neurobiol       Date:  2021-08-26       Impact factor: 5.590

3.  Oral Administration of Copper Chloride Damages DNA, Lowers Antioxidant Defense, Alters Metabolic Status, and Inhibits Membrane Bound Enzymes in Rat Kidney.

Authors:  Nazim Husain; Shaikh Nisar Ali; Hussain Arif; Aijaz Ahmed Khan; Riaz Mahmood
Journal:  Biol Trace Elem Res       Date:  2022-09-07       Impact factor: 4.081

Review 4.  Food Contamination: An Unexplored Possible Link between Dietary Habits and Parkinson's Disease.

Authors:  Giulia Caioni; Annamaria Cimini; Elisabetta Benedetti
Journal:  Nutrients       Date:  2022-03-31       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.